Clinical trial
First Time in Man Study of Finafloxacin Hydrochloride
NCT00483158 · MerLion Pharmaceuticals GmbH, Industry · Completed
Key facts
| NCT number | NCT00483158 |
|---|---|
| Title | First Time in Man Study of Finafloxacin Hydrochloride |
| Official title | A Double-Blind, Placebo-Controlled, Randomized, Dose-Escalating Study of Single and Multiple Oral Doses of Finafloxacin Hydrochloride in Healthy Subjects and a Study of H. Pylori Treatment in Healthy Carriers |
| Lead sponsor | MerLion Pharmaceuticals GmbH, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Helicobacter Infections, Urinary Tract Infection |
| Intervention type | Drug |
| Interventions | Finafloxacin hydrochloride |
| Enrollment | 95 |
| Start date | Aug 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jun 6, 2007 |
| Last update posted | Jul 29, 2008 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: